CYAND
CYANOTECH CORP
Key Financials
Revenue
$24.2M
↑ 5.0%
Gross Profit
$6.9M
↑ 15.7%
Operating Income
$-2508000
↑ 45.4%
Net Income
$-3203000
↑ 39.2%
Cash & Equivalents
$257000.00
↓ 63.6%
Total Liabilities
$14.6M
↑ 9.8%
Total Assets
$23.5M
↓ 6.5%
Shareholders' Equity
$8.9M
↓ 24.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 2/13/2026 | View on SEC |
| SC 13E3/A | 2/13/2026 | View on SEC |
| SC 13E3/A | 2/3/2026 | View on SEC |
| SC 13E3 | 1/9/2026 | View on SEC |
| 10-Q | 11/10/2025 | View on SEC |
| 4 | 9/16/2025 | View on SEC |
| 3 | 9/12/2025 | View on SEC |
| 4 | 9/2/2025 | View on SEC |
| 4 | 9/2/2025 | View on SEC |
| 4 | 9/2/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CYAND |
| Company Name | CYANOTECH CORP |
| CIK | 768408 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | NV |
| Phone | 8083261353 |